<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-103728</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Raynaud, digital ulcers and calcinosis in scleroderma</dc:title>
<dc:description xml:lang="en">Raynaud, digital ulcers and calcinosis are frequent manifestations of patients with systemic sclerosis. Digital ulcers are seen in more than half of the patients with scleroderma. Hospitalizations, ischemic complications and impairment of hand function are frequently observed in patients with digital ulcers, especially if treatment is delayed. Rapid and intensive treatment escalation in patients with scleroderma and refractory Raynaud&#146;s phenomenon is one of the most effective preventive action available in order to avoid the development of digital ulcers and tissue loss(AU)</dc:description>
<dc:creator>Nitsche, Alejandro</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En pacientes con diagnóstico de esclerodermia, el fenómeno de Raynaud, las úlceras digitales y la calcinosis son manifestaciones frecuentes. Las úlceras digitales se observan en más de la mitad de los pacientes. El tratamiento tardío o las secuelas que generan las úlceras digitales con o sin calcinosis conllevan a un deterioro de la capacidad funcional de estos pacientes y complicaciones que pueden requerir hospitalización. El tratamiento escalonado y temprano de los pacientes con esclerodermia y Raynaud refractario constituye la medida preventiva más efectiva para evitar el desarrollo de úlceras digitales y pérdida tisular(AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);8(5): 270-277, sep.-oct.2012. ilus</dc:source>
<dc:identifier>ibc-103728</dc:identifier>
<dc:title xml:lang="es">Raynaud, úlceras digitales y calcinosis en esclerodermia</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d12362^s22012</dc:subject>
<dc:subject>^d2148^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12362^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2148^s22012</dc:subject>
<dc:subject>^d2148^s22054</dc:subject>
<dc:subject>^d2148^s22016</dc:subject>
<dc:subject>^d12976^s22016</dc:subject>
<dc:subject>^d12976^s22012</dc:subject>
<dc:subject>^d12362^s22080</dc:subject>
<dc:subject>^d12976^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>201210</dc:date>
</metadata>
</record>
</ibecs-document>
